Clinical Study

Nemolizumab In Subjects With Prurigo Nodularis

Posted Date: Jan 3, 2022

  • Investigator: Alan Fleischer
  • Specialties:
  • Type of Study: Drug

This is a continuation of a randomized control trial of nemolizumab, an inti-itch drug


Prior Participation In Clinical Trial


Itch, Open Label Extension

For More Information:

Lyssa Casale
513- 558-5650